In the presented study we injected, via dorsal tail vein, MM CD138−CD34−CSCs into NOD/SCID mice and demonstrated that these injected mice developed typical MM-associated symptoms including abnormally poor BMD, high levels of urine protein, high levels of FLC, calcium and IL-6, and impairments in the function of kidney. This evidence concerns the gene IL6 and Miyoshi myopathy.